Gardasil 9 syringe 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FX3BU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $117,519
Award facts
- Contract value 100% obligated
- $117,518.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $117,518.65 delivery order to Amerisourcebergen Drug Corp on May 22, 2026, for Gardasil 9 vaccine syringes with an ultimate completion date of May 26, 2026.
The order is issued under a Defense Logistics Agency indefinite delivery contract for pharmaceutical supply. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FX3BU?
SPE2DR26FX3BU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 22, 2026.
How much is contract SPE2DR26FX3BU worth?
The government has obligated $117,519 on SPE2DR26FX3BU.
Is contract SPE2DR26FX3BU an order under another contract?
Yes. SPE2DR26FX3BU is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX3BU competed?
The extent of competition for SPE2DR26FX3BU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award